tykhr
sign in
free sign up
Arcturus Therapeutics Holdings Inc
Biotechnology
Healthcare
ARCT
27.06 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
8.78
52 week high
32.36
high
10.38
52 week low
8.91
low
8.42
growth
-74.70 %
previous Close
8.91
P/E ratio
market cap
447 M
div yield
0
usd
Sep 2024
qoq
revenue
38.82 M
-15.58 %
net incoming
-6.90 M
59.90 %
eps
0.00 %
59.38 %
eps surprise
78.69 %
net profit margin
-17.78 %
19.00 %
operating incoming
-10.74 M
-300.34 %
net change in cash
-23.15 M
17.52 %
cash on hand
237 M
-24.78 %
cost of revenue
-2.86 M
-417.56 %
top